MedTrace Logo

Monitoring Nociception Using NoL Index to Reduce Opioid-Related Complications in Laparoscopic Abdominal Surgery

NCT06437743 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 282

Last updated 2024-05-31

No results posted yet for this study

Summary

This study aims to determine if optimal intraoperative nociception monitoring using the NoL index can reduce postoperative complications related to opioid use in laparoscopic abdominal surgery. The hypothesis is that guided nociception monitoring decreases opioid-related complications and improves postoperative outcomes.

Conditions

  • Postoperative Opioid-related Complications

Interventions

DEVICE

Nociception Level (NoL) Monitor

The NoL Monitor (PMD-200) is a multi-parameter sensor device placed on the patient's finger to estimate nociception levels during surgery. It provides continuous, real-time feedback to the anesthesiologist on the patient's nociception, assisting in the optimization of analgesic drug administration. The monitor integrates parameters such as heart rate variability, skin conductance, and other physiological signals to compute the NoL index, which ranges from 0 to 100, with target values between 10 and 25 for optimal nociception management.

Sponsors & Collaborators

  • Investigation Group Anesthesia, Resuscitation, And Perioperative Medicine of Aragon

    lead NETWORK

Principal Investigators

  • Ana Pascual-Bellosta, M.D, Ph.D, Prof. · Miguel Servet University Hospital

  • Cristian Aragón-Benedí, M.D, Ph.D · Miguel Servet University Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-06-01
Primary Completion
2025-06-01
Completion
2025-06-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06437743 on ClinicalTrials.gov